Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-15

Clinical Trial Update: Impact of Fecal Microbiota Transplantation in Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating fecal microbiota transplantation for Ulcerative Colitis, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Ulcerative Colitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING